Journals / Medeniyet Medical Journal / 2016 / Cilt: 31 - Sayı: 3

Relationship between papillary thyroid cancer and Hashimoto’s disease

Papiller tiroid karsinomu ile Hashimoto hastalığı arasındaki ilişki

Pages
186–191
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Finally, association between PTC andHashimoto thyroiditis was analyzed, and frequency of Hashimotothyroiditis in PTC patients, and the control group was comparable.The distribution of Hashimoto thyroiditis in patients with PTC wassimilar to those of the control group.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Thyroid cancer is the most frequent type of endocrine system cancers.
📊
Key Findings & Data:Papillary thyroid carcinomas (PTCs) which have favourableprognosis and account for 80% of thyroid cancer.
💡
Conclusion & Impact:Finally, association between PTC andHashimoto thyroiditis was analyzed, and frequency of Hashimotothyroiditis in PTC patients, and the control group was comparable.The distribution of Hashimoto thyroiditis in patients with PTC wassimilar to those of the control group.
🔬Design:Review & Systematic Survey
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Thyroid cancer is the most frequent type of endocrine system cancers. Papillary thyroid carcinomas (PTCs) which have favourableprognosis and account for 80% of thyroid cancer. Hashimoto thyroiditis is the most common cause of hypothroidism in the world. Previous studies demonstrated that chronic inflammation might leadto development of cancer. This paper aimed to determine possiblerelationship between PTC and Hashimoto’s thyroditis. Pathologyarchives of the patients who had been followed up with the diagnosis of thyroid papillary tumors by clinics of endocrinology, andfamily medicine, and undergone thyroidectomy between January2008 and March 2015 were retrospectively reviewed. Patients under 18 years of age were not included in the study the incidence ofHashimoto thyroiditis which accompanied papillary thyroid cancerwas retrospectively investigated. PTC and healthy control groupswith their pathologic and laboratory data were included in thestudy. A total of 87 PTC and 87 healthy subjects were enrolled. Ofall participants, mean age was 47±15 years and male to femaleratio was approximately 1:8. in both groups. Family histories regarding thyroid carcinomas, nonthyroidal malignancies, Hashimoto thyroiditis and systematic autoimmune disease revealed similarincidence rates in both groups (p>0.05, for all). Although PTC patients had higher TSH and fT3 median values, while fT4, anti-TPO,anti-Tg values were similar. Finally, association between PTC andHashimoto thyroiditis was analyzed, and frequency of Hashimotothyroiditis in PTC patients, and the control group was comparable.The distribution of Hashimoto thyroiditis in patients with PTC wassimilar to those of the control group.

Özet

Tiroid kanserleri en sık görülen endokrin sistem kanserleridir. Papiller tiroid karsinomları, tiroid kanserlerinin yaklaşık %80’inini oluşturmaktadır ve en iyi prognozlu tipidir. Hashimoto tiroiditi ise dünyada en sık görülen otoimmun tiroidittir ve hipotiroidizmin en sık nedenidir. Daha önce yapılan çalışmalarda, kronik inflamasyonun kansere yol açabileceği gösterilmiştir. Çalışmamızın amacı, papiller tiroid karsinomunu ile Hashimoto tiroiditi arasında bir ilişki varlığını araştırmaktır. Endokrinoloji ve aile hekimliği kliniklerinden Ocak 2008 ve Mart 2015 tarihleri arasında tiroid papiller karsinomu (PTK) nedeniyle takip edilip, patoloji arşivleri incelenerek tiroidektomi yapılan hastalar tarandı. Yaşı 18’in altında olan hastalar çalışmaya dâhil edilmedi. Retrospektif incelemede, papiller tiroid kanserli hastalara eşlik eden Hashimoto tiroiditi sıklığı araştırıldı. Çalışmaya 87 PTK olgusu ve kontrol grubu olarak aynı sayıda 87 kişi dâhil edilmiştir. Hastalarının yaş ortalaması 47±15 yıl, erkek/kadın oranı iki grupta da yaklaşık olarak 1:8 idi. Olguların aile öyküsünde tiroid karsinomu, tiroid dışı malignite, Hashimoto tiroiditi ve sistemik otoimmun hastalık açısından iki grup arasında farklılık saptanmadı. Hastaların preop tiroid fonksiyon testleri ve antikor değerleri karşılaştırıldığında, PTC olan hastalarda TSH ve sT3 median değerleri anlamlı olarak yüksek, sT4, anti-TPO, anti-Tg değerleri gruplar arasında anlamlı farklılık yoktu. Papiller tiroid karsinomu ile Hashimoto tiroidit arasındaki ilişki incelendiğinde hastaların hashimoto tiroidit sıklığı kontrol grubu ile benzer olduğu görüldü. Papiller tiroid karsinomlu hastaların Hashimoto tiroiditi dağılımı kontrol grubu ile benzerdi.

🔖

Cite This Article

TAKIR, M., ŞENOL, S., ERDOĞMUŞ, S., KÖSTEK, O., MUTLU, H. H. (2022). Relationship between papillary thyroid cancer and Hashimoto’s disease. Medeniyet Medical Journal, Cilt: 31 - Sayı: 3, 186–191. https://ajindex.com/articles/579368

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Tiroid Hastalıklari Tanı ve Tedavi Kılavuzu. Türkiye Endokrinoloji ve Metabolizma Derneği 2015
  2. Mark HB, Robert B. Thyroid disorders.In The Merck Manual, 17th ed. Edit. Mark HB, Robert B. Merck Research Laboratories. NJ, 1999; p:81-100
  3. DeLellis RA, Williams ED. Thyroid and parathyroid tumors; introduction. InTumors of Endocrine Organs, World Health Organization Classification of Tumors. Edit. Ronald ADL, Ricardo VL, Phillip UH, Charis E. 2004; 1st ed., Lyon, p:51
  4. Naweed R, Manish D, Phill M., et al. Risk factors for well differentiated thyroid carcinoma in patients with thyroid nodular disease. Otolaryngology-Head and Neck Surgery 2008;139:21-6.
  5. Shawn DL, Lindsey NJ, Taylor SR, et al: Increased incidence of well differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of PI3K/Akt Pathway. J Am Coll Surg 2007;204:764-75.
  6. Jeong SH, Hong HS, Lee H, et al. Papillary Thyroid Carcinoma Arising in Children and Adolescent Hashimoto’s Thyroiditis: Ultrasonographic and Pathologic Findings. International Journal of Endocrinology 2016.
  7. Singh B, Shaha AR, Triverdi H, et al. Coexistent Hashimoto’s thyroiditis with papillary thyroid carcinoma: Impact on presentation. Management and Outcome Surgery 1999;126:1070-7.
  8. Cipolla C, Sandonato L, Graceffa G, et al. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 2005;71:874-8
  9. Başoğlu M, Karabulut K. İyi diferansiye tiroit kanserleri. Journal of Experimental and Clinical Medicine Deneysel ve Klinik Tıp Dergisi
  10. Bojana Jankovic, Karen T. Le, Jerome M. Hershman. Hashimoto’s Thyroiditis and Papillary Thyroid Carcinoma: Is There a Correlation?. J Clin Endocrinol Metab 2013;98(2):474-82.
  11. Tonbul AT. Kliniğimizde tedavi ve takip edilen 500 diferansiye tiroid karsinomlu olgu örnekleminde demografik özellikler. İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi Nükleer Tıp Kliniği, Uzmanlık Tezi İstanbul 2008
  12. Collins SL. Thyroid cancer: controversies and ethiopathogenesis. In thyroid disease: second edition: Falk SE. Lippincot Raven. Philadelphia 1997;11:495-564
  13. Mintziori G, Adamidou F, Kita M, et al. Hashimoto’s thyroiditis and papillary thyroid cancer: polyglandular hints. Trends in Endocrinology & Metabolism 2015; 26.8: 395.